Exhibition:Global Startup EXPO 2025

2025.08.28

SCIENCE

Provigate Inc. is pleased to announce that we will be exhibiting at the Global Startup EXPO 2025 (GSE 2025), to be held on September 17 (Wed) and 18 (Thu), 2025, at Yumeshima, Osaka.
At our booth, we will present glucoreview®, a new behavior-change service for people with diabetes or prediabetes, centered on weekly glycated albumin (GA) monitoring. The program combines at-home testing, a mobile app, and human support to enable comprehensive blood glucose management. We will also share our track record of adoption by domestic insurers, as well as our plans for international collaborations. Our team is also available for consultations regarding service implementation, sales partnerships, and business collaboration.

Pre-registration is required to attend. While admission to the event itself is free of charge, visitors must register on the official website and obtain an Expo 2025 Osaka–Kansai entrance ticket to access the venue.
Global Startup EXPO 2025 official site: https://global-startup-expo.go.jp/
Expo 2025 Osaka–Kansai official site: https://www.expo2025.or.jp/
We look forward to welcoming you at our booth.

Event Name
Global Startup EXPO 2025

Dates
Wednesday, September 17, 2025 — 9:30 AM to 6:00 PM
Thursday, September 18, 2025 — 10:00 AM to 6:00 PM

Venue
EXPO Messe “WASSE” (A-21), Expo 2025 Osaka–Kansai site, Yumeshima, Osaka City
1 Yumeshima Higashi, Konohana-ku, Osaka 554-0000, Japan

Organizers
Ministry of Economy, Trade and Industry (METI) / Kansai Bureau of Economy, Trade and Industry / Japan External Trade Organization (JETRO) / New Energy and Industrial Technology Development Organization (NEDO)

People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.

There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.

Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.